{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-163395","form_type":"8-K","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.908509+00:00","generated_at":"2026-06-01T03:50:48.884385+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Lyra stockholders approve officer exculpation amendment and elect two Class I directors","bullets":["Officer exculpation amendment approved: 38.8M for, 1.2M against, 8k abstain.","Class I directors elected: Poukalov (38.6M for) and Snyderman (33.4M for).","BDO USA ratified as auditor for FY2024: 47.5M for, 47.7k against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-163395","json":"https://secwatch.observer/filing/0001193125-24-163395.json","markdown":"https://secwatch.observer/filing/0001193125-24-163395.md","text":"https://secwatch.observer/filing/0001193125-24-163395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/0001193125-24-163395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/d614069d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:50:48.884385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}